Literature DB >> 6199637

Side-effects of antileprosy drugs in common use.

W H Jopling.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6199637     DOI： 10.5935/0305-7518.19830032

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

2.  Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1.

Authors:  Richard I Horowitz; Phyllis R Freeman
Journal:  Int J Gen Med       Date:  2019-02-18

3.  Polymorphisms in the CYP2E1 and GSTM1 genes as possible protection factors for leprosy patients.

Authors:  Pablo Pinto; Claudio Guedes Salgado; Ney Santos; Dayse O Alencar; Sidney Santos; Mara H Hutz; Ândrea Ribeiro-dos-Santos
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

4.  Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study.

Authors:  Sanjeev Guragain; Namrata Upadhayay; Bishwa Mohan Bhattarai
Journal:  Clin Pharmacol       Date:  2017-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.